AAPL347.68-0.55 (-0.16%) ▼|ABBV285.80+0.61 (+0.21%) ▲|ABT103.70+1.19 (+1.16%) ▲|ACN249.43-9.31 (-3.60%) ▼|ADBE263.82-6.73 (-2.49%) ▼|AMAT377.24+1.66 (+0.44%) ▲|AMD516.79+8.86 (+1.74%) ▲|AMGN439.26-8.02 (-1.79%) ▼|AMT188.97+7.40 (+4.08%) ▲|AMZN248.00-2.38 (-0.95%) ▼|AVGO321.68-1.56 (-0.48%) ▼|AXP313.06-12.11 (-3.72%) ▼|BA188.29+0.74 (+0.39%) ▲|BAC50.57-0.51 (-1.00%) ▼|BKNG155.83-5.27 (-3.27%) ▼|BLK1,117.92-19.37 (-1.70%) ▼|BMY61.48-1.52 (-2.41%) ▼|BNY145.24-0.08 (-0.06%) ▼|BRK-B542.43-4.54 (-0.83%) ▼|C120.67-1.84 (-1.50%) ▼|CAT686.82-17.23 (-2.45%) ▼|CL94.02-3.37 (-3.46%) ▼|CMCSA22.69-0.15 (-0.66%) ▼|COF201.33-2.10 (-1.03%) ▼|COP150.81+5.18 (+3.56%) ▲|COST1,003.32-14.89 (-1.46%) ▼|CRM248.53-1.76 (-0.70%) ▼|CSCO106.50+1.61 (+1.53%) ▲|CVS93.49-0.99 (-1.05%) ▼|CVX233.24+6.56 (+2.89%) ▲|DE646.01+2.39 (+0.37%) ▲|DHR230.50+0.75 (+0.33%) ▲|DIS112.52-0.61 (-0.54%) ▼|DUK124.98-0.42 (-0.33%) ▼|EMR161.59+1.30 (+0.81%) ▲|FDX298.72-5.20 (-1.71%) ▼|GD349.36-1.43 (-0.41%) ▼|GE285.64-7.90 (-2.69%) ▼|GEV815.00-12.42 (-1.50%) ▼|GILD156.04-1.15 (-0.73%) ▼|GM75.92-1.29 (-1.67%) ▼|GOOG317.28-3.48 (-1.08%) ▼|GOOGL320.21-4.01 (-1.24%) ▼|GS875.68-15.62 (-1.75%) ▼|HD319.83-7.90 (-2.41%) ▼|HON221.15+2.84 (+1.30%) ▲|IBM253.56+1.45 (+0.58%) ▲|INTC86.96+1.47 (+1.72%) ▲|INTU343.39-11.51 (-3.24%) ▼|ISRG452.29+8.44 (+1.90%) ▲|JNJ263.81-3.80 (-1.42%) ▼|JPM331.58-4.96 (-1.47%) ▼|KO92.71-2.63 (-2.76%) ▼|LIN508.83-1.53 (-0.30%) ▼|LLY1,273.46-33.23 (-2.54%) ▼|LMT604.18+14.27 (+2.42%) ▲|LOW198.69-5.68 (-2.78%) ▼|LRCX230.10-0.05 (-0.02%) ▼|MA623.60-9.61 (-1.52%) ▼|MCD248.46-4.17 (-1.65%) ▼|MDLZ63.80-1.39 (-2.13%) ▼|MDT95.41-1.18 (-1.22%) ▼|META642.62-6.23 (-0.96%) ▼|MMM173.48-2.08 (-1.18%) ▼|MO74.32-1.75 (-2.30%) ▼|MRK145.25-1.99 (-1.35%) ▼|MS179.48-4.49 (-2.44%) ▼|MSFT524.51+3.43 (+0.66%) ▲|MU877.55+21.06 (+2.46%) ▲|NEE82.10+0.20 (+0.24%) ▲|NFLX65.85-1.20 (-1.79%) ▼|NKE37.30-1.02 (-2.66%) ▼|NOW158.96+1.96 (+1.25%) ▲|NVDA210.96-1.25 (-0.59%) ▼|ORCL126.16+0.62 (+0.49%) ▲|PEP135.77-3.06 (-2.20%) ▼|PFE30.03-0.39 (-1.28%) ▼|PG161.11-3.39 (-2.06%) ▼|PLTR196.75+0.56 (+0.29%) ▲|PM199.47-2.27 (-1.13%) ▼|QCOM175.91+3.08 (+1.78%) ▲|RTX191.01-3.70 (-1.90%) ▼|SBUX100.80-1.11 (-1.09%) ▼|SCHW90.58-0.86 (-0.94%) ▼|SO92.89-0.93 (-0.99%) ▼|SPG211.63-0.41 (-0.19%) ▼|T20.93-1.81 (-7.96%) ▼|TMO673.82-2.72 (-0.40%) ▼|TMUS146.54-12.25 (-7.71%) ▼|TSLA372.22-2.36 (-0.63%) ▼|TXN284.69+5.19 (+1.86%) ▲|UBER66.70-2.37 (-3.43%) ▼|UNH418.09-6.89 (-1.62%) ▼|UNP292.87-5.22 (-1.75%) ▼|UPS101.06-0.46 (-0.45%) ▼|USB59.58-0.44 (-0.73%) ▼|V407.92-6.42 (-1.55%) ▼|VZ44.66-0.54 (-1.19%) ▼|WFC82.39-0.62 (-0.75%) ▼|WMT119.89-1.23 (-1.02%) ▼|XOM183.21+4.98 (+2.79%) ▲|AAPL347.68-0.55 (-0.16%) ▼|ABBV285.80+0.61 (+0.21%) ▲|ABT103.70+1.19 (+1.16%) ▲|ACN249.43-9.31 (-3.60%) ▼|ADBE263.82-6.73 (-2.49%) ▼|AMAT377.24+1.66 (+0.44%) ▲|AMD516.79+8.86 (+1.74%) ▲|AMGN439.26-8.02 (-1.79%) ▼|AMT188.97+7.40 (+4.08%) ▲|AMZN248.00-2.38 (-0.95%) ▼|AVGO321.68-1.56 (-0.48%) ▼|AXP313.06-12.11 (-3.72%) ▼|BA188.29+0.74 (+0.39%) ▲|BAC50.57-0.51 (-1.00%) ▼|BKNG155.83-5.27 (-3.27%) ▼|BLK1,117.92-19.37 (-1.70%) ▼|BMY61.48-1.52 (-2.41%) ▼|BNY145.24-0.08 (-0.06%) ▼|BRK-B542.43-4.54 (-0.83%) ▼|C120.67-1.84 (-1.50%) ▼|CAT686.82-17.23 (-2.45%) ▼|CL94.02-3.37 (-3.46%) ▼|CMCSA22.69-0.15 (-0.66%) ▼|COF201.33-2.10 (-1.03%) ▼|COP150.81+5.18 (+3.56%) ▲|COST1,003.32-14.89 (-1.46%) ▼|CRM248.53-1.76 (-0.70%) ▼|CSCO106.50+1.61 (+1.53%) ▲|CVS93.49-0.99 (-1.05%) ▼|CVX233.24+6.56 (+2.89%) ▲|DE646.01+2.39 (+0.37%) ▲|DHR230.50+0.75 (+0.33%) ▲|DIS112.52-0.61 (-0.54%) ▼|DUK124.98-0.42 (-0.33%) ▼|EMR161.59+1.30 (+0.81%) ▲|FDX298.72-5.20 (-1.71%) ▼|GD349.36-1.43 (-0.41%) ▼|GE285.64-7.90 (-2.69%) ▼|GEV815.00-12.42 (-1.50%) ▼|GILD156.04-1.15 (-0.73%) ▼|GM75.92-1.29 (-1.67%) ▼|GOOG317.28-3.48 (-1.08%) ▼|GOOGL320.21-4.01 (-1.24%) ▼|GS875.68-15.62 (-1.75%) ▼|HD319.83-7.90 (-2.41%) ▼|HON221.15+2.84 (+1.30%) ▲|IBM253.56+1.45 (+0.58%) ▲|INTC86.96+1.47 (+1.72%) ▲|INTU343.39-11.51 (-3.24%) ▼|ISRG452.29+8.44 (+1.90%) ▲|JNJ263.81-3.80 (-1.42%) ▼|JPM331.58-4.96 (-1.47%) ▼|KO92.71-2.63 (-2.76%) ▼|LIN508.83-1.53 (-0.30%) ▼|LLY1,273.46-33.23 (-2.54%) ▼|LMT604.18+14.27 (+2.42%) ▲|LOW198.69-5.68 (-2.78%) ▼|LRCX230.10-0.05 (-0.02%) ▼|MA623.60-9.61 (-1.52%) ▼|MCD248.46-4.17 (-1.65%) ▼|MDLZ63.80-1.39 (-2.13%) ▼|MDT95.41-1.18 (-1.22%) ▼|META642.62-6.23 (-0.96%) ▼|MMM173.48-2.08 (-1.18%) ▼|MO74.32-1.75 (-2.30%) ▼|MRK145.25-1.99 (-1.35%) ▼|MS179.48-4.49 (-2.44%) ▼|MSFT524.51+3.43 (+0.66%) ▲|MU877.55+21.06 (+2.46%) ▲|NEE82.10+0.20 (+0.24%) ▲|NFLX65.85-1.20 (-1.79%) ▼|NKE37.30-1.02 (-2.66%) ▼|NOW158.96+1.96 (+1.25%) ▲|NVDA210.96-1.25 (-0.59%) ▼|ORCL126.16+0.62 (+0.49%) ▲|PEP135.77-3.06 (-2.20%) ▼|PFE30.03-0.39 (-1.28%) ▼|PG161.11-3.39 (-2.06%) ▼|PLTR196.75+0.56 (+0.29%) ▲|PM199.47-2.27 (-1.13%) ▼|QCOM175.91+3.08 (+1.78%) ▲|RTX191.01-3.70 (-1.90%) ▼|SBUX100.80-1.11 (-1.09%) ▼|SCHW90.58-0.86 (-0.94%) ▼|SO92.89-0.93 (-0.99%) ▼|SPG211.63-0.41 (-0.19%) ▼|T20.93-1.81 (-7.96%) ▼|TMO673.82-2.72 (-0.40%) ▼|TMUS146.54-12.25 (-7.71%) ▼|TSLA372.22-2.36 (-0.63%) ▼|TXN284.69+5.19 (+1.86%) ▲|UBER66.70-2.37 (-3.43%) ▼|UNH418.09-6.89 (-1.62%) ▼|UNP292.87-5.22 (-1.75%) ▼|UPS101.06-0.46 (-0.45%) ▼|USB59.58-0.44 (-0.73%) ▼|V407.92-6.42 (-1.55%) ▼|VZ44.66-0.54 (-1.19%) ▼|WFC82.39-0.62 (-0.75%) ▼|WMT119.89-1.23 (-1.02%) ▼|XOM183.21+4.98 (+2.79%) ▲|
15.7 C
New York
Friday, October 23, 2026

Health Care

Consumer GoodsConsumer ServicesEconomyEnergyFinanceHealth CareHow To InvestIndustrialsMaterials

Artprice Congratulates Brognon Rollin Winners of the 2026 Marcel Duchamp Prize

Thought and Human Experience at the Heart of CreationPARIS, Oct. 23, 2026 /PRNewswire/ -- A longstanding partner of the Marcel Duchamp Prize, Artprice by Artmarket congratulates the duo Brognon...
Consumer Services prnewswire -

Dow and Small Caps Climb Weekly While Nasdaq Slips on Megacap Earnings Charges

VANCOUVER, BC, Oct. 23, 2026 /CNW/ -- Stock Preachers News Commentary - Stocks closed a...
Finance prnewswire -

Cumberland Pharmaceuticals Announces ASSIST-SSc Trial Top-Line Results

Ifetroban was well tolerated in patients with systemic sclerosis NASHVILLE, Tenn., Oct. 23, 2026...
Energy prnewswire -

ABARTA COCA-COLA TEAMSTERS LAUNCH ULP STRIKE

Members of Local 110 Demand Fair Contract, Affordable Health CareEBENSBURG, Pa., Oct. 23, 2026...
Consumer Goods prnewswire -

Leland Little Announces Charleston, South Carolina Location

HILLSBOROUGH, N.C., Oct. 23, 2026 /PRNewswire/ -- Leland Little Auctions is pleased to announce...
Press Releases prnewswire -
Latest

PK brand Roasted Lemon N’ Chilli Peanuts recalled due to Salmonella

OTTAWA, ON, Sept. 11, 2026 /CNW/ --Product: Roasted Lemon N' Chilli PeanutsIssue: Food - Microbial contamination - SalmonellaDistribution: OntarioQuebecSee the affected products and product photos...

Cardiol Therapeutics Files US$150 Million Preliminary Base Shelf Prospectus Including Additional Disclosure Following Review by Staff of the Ontario Securities Commission

TORONTO, Sept. 10, 2026 /CNW/ -- Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL) ("Cardiol" or the "Company"), a late-stage life sciences company advancing anti-inflammatory...

Cytonics Completes $4.8 Million Gross-Proceeds Financing Campaign

Clinical-stage biotechnology company adds approximately 900 new investors, expands its cap table to approximately 8,000, and brings total capital raised to $47 millionJUPITER, Fla.,...

Hospice Expert Demetress Harrell Explains How Hospice Care Supports Families in HelloNation

The article outlines how hospice services provide caregiver support, grief support services, and emotional support for families beyond the patient.LUFKIN, Texas, Sept. 3, 2026...

Fitness Ventures, Largest Crunch Fitness Franchisee, brings 106 Crunch Fitness Locations and 100+ Fire Departments Together for Nationwide 9/11 Remembrance Stair Climb Challenge

Thousands Expected to Climb 110 Flights in Tribute to First Responders on the 25th Anniversary of September 11ORLANDO, Fla., Sept. 2, 2026 /PRNewswire/ --...

Outlook Therapeutics Announces LYTENAVA™ FDA Approval as the First and Only FDA-Approved Ophthalmic Bevacizumab for the Treatment of Wet AMD

Landmark FDA Approval Is an Important Milestone in Retina Care, Bringing Patients and Physicians an Ophthalmic Bevacizumab Developed Specifically for the Eye Following Years of Rigorous Clinical and Regulatory Evaluation

FDA Approves TYLENOL® with Naproxen, the First and Only Over-the-Counter Fixed-Dose Combination of Acetaminophen (650 mg) and Naproxen Sodium (220 mg)

TYLENOL® with Naproxen is a clinically proven, opioid-free, fixed-dose combination that begins working in under 30 minutes and provides 12 hours of pain relief...

Laminar Pharma Announces “Last Patient, Last Visit” in LAM561 Phase 2b/3 Trial for Newly Diagnosed Glioblastoma Patients

PALMA DE MALLORCA, Spain, July 23, 2026 /CNW/ -- Laminar Pharma, a leader in the development of innovative therapies based on a novel membrane lipid...

Scribe Therapeutics Announces Pricing of Upsized Initial Public Offering

Scribe Therapeutics announces pricing of upsized initial public offering

Save Remote Monitoring Coalition Launches to Oppose Flawed CMS Proposals in the 2027 Physician Fee Schedule

Providers and remote monitoring companies unite to defend a proven Medicare benefit and to demand real enforcement against bad actors in place of structural...

Core Axis Introduces Science-Driven Supplement Protocol Developed Specifically for Hashimoto’s Thyroiditis

Cheyenne, Wyoming, July 23, 2026 (GLOBE NEWSWIRE) -- Core Axis, a health brand founded by MC Bio-Logic LLC, announces the upcoming launch of its daily supplement protocol developed with Hashimoto's thyroiditis in mind. Hashimoto's thyroiditis is the autoimmune condition that affects an estimated five million Americans and remains the leading cause of hypothyroidism in the United States. Designed using evidence-based ingredient selection and clinically relevant dosages, the new protocol addresses nutritional factors relevant to individuals with autoimmune thyroid conditions rather than providing general thyroid support. The company is now inviting individuals to join its early access waitlist ahead of the official product launch.

Marquis Who’s Who Honors Weiqing Gu, PhD, for Expertise in AI and Healthcare

UNIONDALE, N.Y., July 22, 2026 /PRNewswire/ -- Marquis Who's Who honors Weiqing Gu, PhD, for expertise in AI and healthcare. Dr. Gu is the...

Supernus Pharmaceuticals to Announce Second Quarter 2026 Financial Results and Host Conference Call on August 4, 2026

ROCKVILLE, Md., July 22, 2026 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a biopharmaceutical company focused on developing and commercializing products for the treatment of central nervous system (CNS) diseases, today announced that it will report second quarter 2026 financial and business results after the market closes on Tuesday, August 4, 2026.

The Lundquist Institute Launches the Nation’s First Adult Exercise Medicine Fellowship

New physician fellowship, leadership of the Academy of Exercise Medicine, and groundbreaking scientific research position The Lundquist Institute at the forefront of the emerging field of Exercise Medicine. 
New physician fellowship, leadership of the Academy of Exercise Medicine, and groundbreaking scientific research position The Lundquist Institute at the forefront of the emerging field of Exercise Medicine.

- A word from our sponsors -

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomePress ReleasesHealth Care

Explore

Press Releases

News & Opinion

Living

Others

Follow us

© Copyright 2025. BusinessPressWire® / 14 Wall Street New York City NY 10005 +1 888-502-0266 / Disclaimers